Integrative analysis prioritizes proteins associated with renal cell carcinoma and its risk factors

JNCI Cancer Spectrum · Published 2026-07-10 · DOI 10.1093/jncics/pkag074

Free full text

Authors (8)

Ibrahim Hossain Sajal, Andrew J Song, Kevin M Brown, Mitchell J Machiela, Peter Kraft, Stephen Chanock, Mark P Purdue, Diptavo Dutta

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Sajal, I., Song, A., Brown, K., et al. (2026). Integrative analysis prioritizes proteins associated with renal cell carcinoma and its risk factors. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkag074

Related articles

• Y-box binding protein-1 at the crossroads of DNA damage response and tumor immune evasion · JNCI Cancer Spectrum · 2026 · Same journal
• Luteinizing hormone-releasing hormone in prostate cancer treatment: from hypothalamic discovery to clinical translation · JNCI Cancer Spectrum · 2026 · Same journal
• Computational identification of salient cancer care topics and themes in oncology social work notes · JNCI Cancer Spectrum · 2026 · Same journal
• Trends in adult exclusive and dual use of combustible and non-combustible tobacco products in the United States · JNCI Cancer Spectrum · 2026 · Same journal
• Sociodemographic trends in prostate cancer: Insights from the all of Us research program · JNCI Cancer Spectrum · 2026 · Same journal
• Feasibility evaluation of a virtual lifestyle intervention for early-stage breast cancer survivors undergoing chemotherapy · JNCI Cancer Spectrum · 2026 · Same journal
• Clinical outcomes in pediatric acute lymphoblastic leukemia using modified BFM-95 protocol: 10-year study in Mexico City · JNCI Cancer Spectrum · 2026 · Same journal
• Emergency cancer diagnosis in older adults: patterns, subgroups, and implications for health-care quality metrics · JNCI Cancer Spectrum · 2026 · Same journal
• Contrastive multimodal deep learning for survival prediction in grade 2/3 gliomas · JNCI Cancer Spectrum · 2026 · Same journal
• Bone and soft tissue sarcoma mortality in 19 811 patients diagnosed in Japan, 2006-2020 · JNCI Cancer Spectrum · 2026 · Same journal